Modulation of regional brain function by deep brain stimulation: Studies with positron emission tomography

Current Opinion in Neurology

Volumn 15, Issue 4, 2002, Pages 451-455

  Carbon, Maren ^a   Eidelberg, David ^a  

^a Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN REGION; EDITORIAL; HUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY;

BRAIN; ELECTRIC STIMULATION THERAPY; HUMANS; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036316391     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200208000-00008     Document Type: Editorial

References (43)

1. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
2. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease
3. Lesions of the basal ganglia and surgery for Parkinson's disease
4. Neurophysiologic aspects of deep brain stimulation
5. Mechanism of action of deep brain stimulation
6. Deep brain stimulation for Parkinson's disease
7. Cognitive outcomes after deep brain stimulation for Parkinson's disease: A review of initial studies and recommendations for future research
8. The impact of deep brain stimulation on executive function in Parkinson's disease
9. Neuropsychological changes between STN or GPi stimulation in Parkinson's disease
10. Movement disorders: Parkinson's disease
11. The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies
12. The metabolic topography of parkinsonism
13. Reproducibility of regional metabolic covariance patterns: Comparison of four populations
14. Functional and pathophysiological models of the basal ganglia
15. ECD/SPECT in the differential diagnosis of parkinsonism
16. Metabolic correlates of levodopa response in Parkinson's disease
17. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET
18. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography
19. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing
20. Increasing activity of abnormal metabolic brain networks with the progression of Parkinson's disease
21. Metabolic correlates of pallidal neuronal activity in Parkinson's disease
22. Clues for metabolic topography of executive dysfunction in Parkinson's disease
23. Relationships between the metabolic patterns that correlated with mnemonic, visuospatial, and mood symptoms in Parkinson's disease
24. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions
25. The metabolic topography of normal aging
26. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A PET study of resting-state glucose metabolism
27. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease
28. Metabolic changes following subthalamotomy for advanced Parkinson's disease
29. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation
30. The role of cortico-striatal circuits in learning sequential information
31. Functional networks in motor sequence learning: Abnormal topographies in Parkinson's disease
32. The differential effect of Parkinson's disease and normal aging on sequence learning
33. Parallel neural networks for learning sequential procedures
34. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability
35. Patterns of regional brain activation associated with different aspects of motor learning
36. Functional correlates of pallidal stimulation for Parkinson's disease
37. Effects of levodopa infusion on motor activation responses in Parkinson's disease
38. A review of differences between basal ganglia and cerebellar control of movements as revealed by functional imaging studies
39. Therapeutic modulation of motor sequence learning networks in Parkinson's disease
40. Pallidal stimulation for parkinsonism: Improved brain activation during sequence learning
41. What do the basal ganglia do?
42. Dopaminergic modulation of cortical function in patients with Parkinson's disease
43. Transition of brain activation from frontal to parietal areas in visuomotor sequence learning